Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Roche diabetes trial proves promising

February 11, 2010 Research and Development GLP-1, Roche, diabetes, taspoglutide

Phase III results for Roche’s once-weekly injectable drug taspoglutide have shown a positive effect on reducing blood glucose compared with …
News

Oral strip ondansetron held up at FDA

February 11, 2010 Manufacturing and Production, Research and Development Strativa, chemotherapy, film strips, nausea

A novel formulation of ondansetron has seen its marketing application delayed at the US Food and Drug Administration (FDA) because …
News

GSK to downsize Harlow R&D site

February 10, 2010 Research and Development GlaxoSmithKline, job cuts

GlaxoSmithKline is on the point of making the first job cuts in a round of redundancies designed to save £500 …
News
Novartis' Olivier Leupin

Working Life: Olivier Leupin

February 9, 2010 Business Services, Research and Development Novartis, Working Life, careers, careers voice

How did you find your way into your most current role? After receiving a master’s degree in biology at the …
Feature

ICON promotes Tom O’Leary

February 9, 2010 Research and Development ICON, appointment, research and development

Tom O’Leary has been appointed president of ICON Central Laboratories, succeeding Bob Scott-Edwards. Scott-Edwards had held the role since August …
Appointment

Pfizer to personalise brain tumour vaccine

February 8, 2010 Research and Development Pfizer, Qiagen, brain tumour, gliobastoma, vaccines

Pfizer is working with Dutch company Qiagen to develop a companion diagnostic kit for its immunotherapy vaccine for gliobastoma multiforme. …
News
Blog footer

Digital Pharma: UCB’s online epilepsy community

February 8, 2010 Medical Communications, Research and Development PatientsLikeMe, UCB, community, digital pharma, digital pharma research, patient information

UCB has launched an online community for US epilepsy patients to record ‘real-world’ experiences of the condition. In addition to …
Feature

GSK looks to rare diseases research

February 5, 2010 Research and Development GlaxoSmithKline, Orphan

GlaxoSmithKline has launched a new specialist unit to research and develop medicines for rare diseases. The company has identified 5,500 …
News
ABPI

Barker praises OLS model

February 5, 2010 Research and Development, Sales and Marketing ABPI, Blueprint, OLS

The ABPI’s director general spoke to Pharmafocus about the promise of the new Blueprint at its launch in London last …
News
Andrew Witty

GSK confirms job cuts but avoids specifics

February 5, 2010 Research and Development, Sales and Marketing 2009 financials, GlaxoSmithKline

GlaxoSmithKline has sidestepped questions about the internal fall-out from its new plan to slash R&D infrastructure costs. Presenting the company’s …
News
Photo_Miguel_Forte300dpi

Miguel Forte joins TxCell

February 5, 2010 Research and Development TxCell, appointment, research and development

French biotech TxCell has appointed Miguel Forte to fill its newly-created role of chief medical officer. Miguel joins the company …
Appointment

GSK acquires respiratory candidate

February 4, 2010 Research and Development Apeiron, GlaxoSmithKline, respiratory

GlaxoSmithKline has acquired exclusive rights to a biotherapeutic enzyme developed for use against Acute Respiratory Distress Syndrome (ARDS). The move …
News

Lancet retracts MMR research conclusions

February 3, 2010 Research and Development MMR, Sanofi, vaccines

The Lancet, the journal which originally published the controversial research linking the MMR vaccine to autism has issued a full …
News

Digital Pharma: New EMA website previewed

February 3, 2010 Research and Development, Sales and Marketing EMA, branding, digital pharma

The European Medicines Agency is preparing to overhaul its website to make it easier for users to get information. This …
News

FDA to assess Neupogen biosimilar

February 3, 2010 Research and Development, Sales and Marketing Hospira, Teva, biosimilars

US regulator the FDA has agreed to assess Teva’s application for a biosimilar version of Amgen’s Neupogen (filgrastim). XM02, a …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025